|
Huang, Rong; Oh, Hyunju; Arrendale, Allison et al. (2013) Intracellular targets for a phosphotyrosine peptidomimetic include the mitotic kinesin, MCAK. Biochem Pharmacol 86:597-611
|
|
Marian, Christine; Huang, Rong; Borch, Richard F (2011) Design and synthesis of a potential SH2 domain inhibitor bearing a stereodiversified 1,4-cis-enediol scaffold. Tetrahedron 67:10216-10221
|
|
Clark, Michelle K; Scott, Sarah A; Wojtkowiak, Jonathan et al. (2007) Synthesis, biochemical, and cellular evaluation of farnesyl monophosphate prodrugs as farnesyltransferase inhibitors. J Med Chem 50:3274-82
|
|
Choi, Jun Young; Borch, Richard F (2007) Highly efficient synthesis of enantiomerically enriched 2-hydroxymethylaziridines by enzymatic desymmetrization. Org Lett 9:215-8
|
|
Wu, Weidong; Sigmond, Jennifer; Peters, Godefridus J et al. (2007) Synthesis and biological activity of a gemcitabine phosphoramidate prodrug. J Med Chem 50:3743-6
|
|
Boutselis, Irene G; Yu, Xiao; Zhang, Zhong-Yin et al. (2007) Synthesis and cell-based activity of a potent and selective protein tyrosine phosphatase 1B inhibitor prodrug. J Med Chem 50:856-64
|
|
Garrido-Hernandez, Hugo; Moon, Kyung D; Geahlen, Robert L et al. (2006) Design and synthesis of phosphotyrosine peptidomimetic prodrugs. J Med Chem 49:3368-76
|
|
Wu, Weidong; Borch, Richard F (2006) Synthesis and biological activity of N-2,3-dihydroxypropyl-N-4-chlorobutyl nucleoside phosphoramidate prodrugs. Mol Pharm 3:451-6
|
|
Wu, Weidong; Freel Meyers, Caren L; Borch, Richard F (2004) A novel method for the preparation of nucleoside triphosphates from activated nucleoside phosphoramidates. Org Lett 6:2257-60
|
|
Tobias, Sandra C; Borch, Richard F (2004) Synthesis and biological evaluation of a cytarabine phosphoramidate prodrug. Mol Pharm 1:112-6
|
Showing the most recent 10 out of 32 publications
